Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

IGF-I peptides useful in ophthalmology and dermatology

Aug. 4, 2003

IOP-lowering agents prepared and tested by Alcon researchers

July 28, 2003

CG-5601, a potential alternative to thalidomide for ocular inflammation

July 11, 2003

Minimal VEGF exon 6-encoded sequence with antiangiogenic activity identified

July 7, 2003

CA4P evaluated for potential in wet AMD

July 7, 2003

Inspire files first NDA for ocular therapy partnered with Allergan

July 2, 2003

New aciclovir prodrugs and their use in ocular viral infections

July 2, 2003

Novartis Ophthalmics obtains development and marketing license for Lucentis

June 27, 2003

Enrollment completed in phase II/III European trial of Trabio

June 19, 2003

Synthetic retinal peptide improves functional activity in diabetic retinopathy

June 19, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...